Information Provided By:
Fly News Breaks for June 29, 2016
ALXN
Jun 29, 2016 | 09:08 EDT
Cowen believes investors should use the weakness in Alexion as a buying opportunity. The firm expects the company to post industry leading growth for the foreseeable future and cites events such as Brexit, Latin American headwinds, and Soliris biosimilars as inconsequential. Cowen reiterated its Outperform rating and $216 price target on Alexion shares.
News For ALXN From the Last 2 Days
There are no results for your query ALXN